Literature DB >> 22767631

New players in the pathogenesis of focal segmental glomerulosclerosis.

Christoph Schell, Tobias B Huber.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is the most common primary glomerular disorder causing end-stage renal disease. Since the first description of this clinicopathological entity in the early 1930s, various studies have identified numerous underlying pathogenetic mechanisms. Nevertheless, FSGS is still a complex, only partially understood and in its classification sometimes confusing disease. A unifying pathophysiological concept has not been identified and might not even exist. However, research efforts of past decades identified FSGS as a podocytopathy with several podocyte molecules being key players in the development and the course of FSGS. Podocytes are crucially involved in the formation of the glomerular barrier and any assault on their delicate physiological balance and architecture can result in the development of proteinuria. The following review article will introduce most recent examples identifying novel players in the complex pathogenesis of FSGS.

Entities:  

Mesh:

Year:  2012        PMID: 22767631     DOI: 10.1093/ndt/gfs273

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Could Autophagic Exhaustion Be a Final Common Pathway for Podocytopathy in FSGS?

Authors:  Manjeri A Venkatachalam
Journal:  J Am Soc Nephrol       Date:  2014-11-18       Impact factor: 10.121

Review 2.  Podocytes proliferate: novel mechanism identified in collapsing glomerulopathies.

Authors:  Cheng Zhu; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

Review 3.  Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.

Authors:  Sun-Ji Park; Yeawon Kim; Ying Maggie Chen
Journal:  Pediatr Nephrol       Date:  2018-08-11       Impact factor: 3.714

Review 4.  Focal Segmental Glomerulosclerosis.

Authors:  Avi Z Rosenberg; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-27       Impact factor: 8.237

5.  α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.

Authors:  Xuan Zhao; Kuo-Sheng Hsu; Jun Hee Lim; Leslie A Bruggeman; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2014-11-19       Impact factor: 5.157

6.  IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.

Authors:  Yipeng Liu; Wei Liang; Yingjie Yang; Yangbin Pan; Qian Yang; Xinghua Chen; Pravin C Singhal; Guohua Ding
Journal:  Cell Signal       Date:  2015-01-31       Impact factor: 4.315

7.  TRPC6 Binds to and Activates Calpain, Independent of Its Channel Activity, and Regulates Podocyte Cytoskeleton, Cell Adhesion, and Motility.

Authors:  Louise K Farmer; Ruth Rollason; Daniel J Whitcomb; Lan Ni; Alexander Goodliff; Abigail C Lay; Lutz Birnbaumer; Kate J Heesom; Shang-Zhong Xu; Moin A Saleem; Gavin I Welsh
Journal:  J Am Soc Nephrol       Date:  2019-08-15       Impact factor: 14.978

8.  Pathogenic pathways are activated in each major cell type of the glomerulus in the Cd2ap mutant mouse model of focal segmental glomerulosclerosis.

Authors:  Eric W Brunskill; S Steven Potter
Journal:  BMC Nephrol       Date:  2015-05-13       Impact factor: 2.388

9.  Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.

Authors:  Howard Trachtman; Suzanne Vento; Emily Herreshoff; Milena Radeva; Jennifer Gassman; Daniel T Stein; Virginia J Savin; Mukut Sharma; Jochen Reiser; Changli Wei; Michael Somers; Tarak Srivastava; Debbie S Gipson
Journal:  BMC Nephrol       Date:  2015-07-22       Impact factor: 2.388

10.  p47(phox) contributes to albuminuria and kidney fibrosis in mice.

Authors:  Hongtao Wang; Xiwu Chen; Yan Su; Paisit Paueksakon; Wen Hu; Ming-Zhi Zhang; Raymond C Harris; Timothy S Blackwell; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2015-01-07       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.